MEDICINES Australia (MA)has welcomed the Federal Government's modifications to Australia's skilled migration occupation lists announced on Friday 30 June.
"These changes will prevent workforce and skill shortages within the critical innovative pharmaceutical sector," Medicines Australia ceo Milton Catelin said.
"As an industry that is so reliant on research and development and a workforce with very specific abilities, it's important that we have a skilled migration policy that can support the ongoing work of this vital sector to Australia."
Australian biotech company AusBiotech has been lobbying for a reinstatement of 457 visas across a range of highly skilled roles including industrial pharmacists, and has also welcomed the reinstatement as a means of addressing the skills gap in the life science industry.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jul 17